Estradiol, Norethindrone Acetate Articles
Novo Nordisk enrolls Innovex for menopause drugs sales
29 March 2004
Pfizer tries to end Novo HRT deal
9 June 2003
Novo Nordisk and AHP settle HRT litigation
21 June 2000
Novo Nordisk and AHP settle patent dispute
16 June 2000
Pharmacia gains FDA OK for Activella
18 April 2000
P&U to market Novo Nordisk's HRT drugs in USA
13 January 2000
Showing 1-6 of 6 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
